Last edition
News about Global Pharma
ScreenPoint Medical Deploys Transpara Breast AI at Johns Hopkins to Improve Cancer Detection
The Johns Hopkins Kimmel Cancer Center was one of the first to be recognized by the National Cancer Institute as a 'Center of Excellence.'
Global Pharma | 12/03/2024 | By Manvi | 533
The collaboration aims to significantly accelerate the development and commercialization of Ratio's pipeline of next-generation radiotherapies, representing a critical component in advancing Ratio's fibroblast activation protein-alpha (FAP)-targeted radiotherapeutic candidate.
Global Pharma | 12/03/2024 | By Manvi | 828
Syntegon's SBM Introduces New Sterilizer Series for Pharmaceutical Manufacturers
Christian Dallner, SBM's product manager, highlights the standardized basis of the SBM Essential Line, which promises shorter delivery times and competitive prices for pharmaceutical manufacturers.
Global Pharma | 12/03/2024 | By Abha | 1077
Gennova BioPharma Announces the Launch of HAMSYL Junior
Gennova Biopharmaceuticals Ltd., announces the launch of the India’s first paediatric pack size of pegaspargase – HAMSYL – Junior, which will now be available in a 1500 IU pack size.
Global Pharma | 11/03/2024 | By Manvi | 1260
These are important steps to providing a full suite of ketamine options for customers across the country, and preparation for potential approval of HTX-100 by regulatory authorities worldwide.
Global Pharma | 11/03/2024 | By Manvi | 376
FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Obesity
Obesity and overweight afflict approximately 70 percent of American adults, posing grave health hazards that elevate the likelihood of premature mortality and a spectrum of health ailments, including heart attack and stroke.
Global Pharma | 11/03/2024 | By Abha | 1207
PulseCath Achieves MDR CE Certification for iVAC 2L System
This certification signifies PulseCath's unwavering dedication to upholding the highest standards of quality and safety in medical device technology.
Global Pharma | 11/03/2024 | By Abha | 451
Vanda Pharmaceuticals Receives Complete Response Letter from FDA for Insomnia Treatment
The issuance of the CRL signifies that the FDA cannot approve the sNDA in its current form, as confirmed by Vanda.
Global Pharma | 07/03/2024 | By Abha | 576
Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer
Jamie is set to succeed Hans Cobben, who has served as the interim CEO and will revert to his position as Chairman of the Board at Velsera.
Global Pharma | 06/03/2024 | By Manvi | 315
Clear Guide Medical Receives FDA Clearance for SCENERGY System
The CLEAR GUIDE SCENERGY system represents a leap forward in image-guided diagnostic and interventional procedures, offering unparalleled accuracy and precision.
Global Pharma | 06/03/2024 | By Abha | 488
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy